Mr. John Miller reports

THC BIOMED INTL LTD. (THC.CSE, THCBF - OTC, TFHD.F) ANNOUNCES STRATEGIC OPERATIONAL RESTRUCTURING, TARGETS MICRO-PRODUCERS

THC Biomed Intl Ltd. has revealed a decisive strategic restructuring of operations.

Focusing on service expansion, the company now offers comprehensive assistance to microproducers seeking entrance into the lucrative cannabis sector.

This announcement follows the recent launch of THC Biomed's medical cannabis dispensary, THC2GO, in Thailand. The company's global expansion initiatives illustrate its dedication to market diversification and broader impact.

In the wake of the company's shift to edibles and drinks as its main products, THC Biomed has available grow space in its licensed Kelowna, B.C., facility. This space will be leveraged to offer turnkey operations for microproducers, inclusive of a licensed grow space and consulting services covering all facets of cannabis production, from growth to extraction, distribution and sales.

"Transitioning to edibles and drinks, coupled with our Clone Shipper sales, we now have space to accommodate a few microproducers," stated John Miller, chief executive officer of THC Biomed. "This new direction allows us to contribute to the growing trend toward microproducers in the Canadian cannabis market, aiding newcomers in navigating market entry barriers."

As a result of the more streamlined process with edibles and drinks production, some units have been earmarked to be sold as commercial units in the Akland Road business park.

Microproducers utilizing THC's services will gain from the company's existing licence, in-house processing and established distribution networks. THC Biomed will also assist these new microproducers in applying for a B.C. farmgate licence, facilitating non-medical cannabis product sales from stores located at cultivation sites.

As a licensed producer since 2016 and first licensed to handle cannabis in 2013, THC Biomed brings considerable expertise to this initiative. It continues its commitment to quality, innovation and diversity within the cannabis market.

About THC Biomed Intl Ltd.

THC Biomed is one of Canada's oldest active licensed cannabis companies. It was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a licensed producer under the current regime since 2016. Its product focus is on high-quality, high-potency beverages and edibles.

THC Biomed is a Cannabis Act licensed producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The company is on the leading edge of scientific research and the development of products and services in the medical and recreational cannabis industry. Management believes THC Biomed is well positioned to be in the forefront of this industry.

We seek Safe Harbor.